Showing results (1-10 of 156) with videos related to
Sort By:
Pageof 16
Frontiers in Bioscience : a Journal and Virtual Library|December 22, 2005
Laboratory analysis of T-cell immunityKeith L Knutson, Corazon dela Rosa, Mary Lenora DisisBlood|April 4, 2002
Flt3 ligand as a vaccine adjuvant in association with HER-2/neu peptide-based vaccines in patients with HER-2/neu-overexpressing cancersMary L Disis, Kristine Rinn, Keith L Knutson, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2007
Tumor antigen-specific T-cell expansion is greatly facilitated by in vivo primingYushe Dang, Keith L Knutson, Vivian Goodell, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 15, 2004
Effect of dose on immune response in patients vaccinated with an her-2/neu intracellular domain protein--based vaccineMary L Disis, Kathy Schiffman, Katherine Guthrie, et al.BMC Immunology|September 14, 2007
Sensitivity and specificity of tritiated thymidine incorporation and ELISPOT assays in identifying antigen specific T cell immune responsesVivian Goodell, Corazon dela Rosa, Meredith Slota, et al.Current Opinion in Molecular Therapeutics|September 12, 2002
Technology evaluation: DCVax, Northwest BiotherapeuticsKeith L KnutsonCurrent Opinion in Investigational Drugs (London, England : 2000)|June 11, 2002
GMK (Progenics Pharmaceuticals)Keith L KnutsonFuture Oncology (London, England)|June 22, 2006
Strong-arming immune regulation: suppressing regulatory T-cell function to treat cancersKeith L KnutsonJournal of Immunology (Baltimore, Md. : 1950)|April 15, 2024
Regulation of Tumor Dendritic Cells by Programmed Cell Death 1 PathwaysKeith L KnutsonCancer Biomarkers : Section a of Disease Markers|October 13, 2010
Antibodies in cancer immunotherapyLavakumar Karyampudi, Keith L KnutsonPageof 16